Fortress Biotech (FBIO) Capital Expenditures Growth (1y) (2016 - 2024)
Powered by 
Analysis
Fortress Biotech (FBIO) Capital Expenditures Growth (1y) (2016 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | -22.99% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 9.68% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 1,133.33% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | -37.81% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 142.64% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 22,433.30% |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -73.62% |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -139,600.00% |
| Jun 30, 2024 | 8,618.75% |
| Dec 31, 2023 | -69.23% |
| Sep 30, 2023 | -99.90% |
| Jun 30, 2023 | -94.79% |
| Mar 31, 2023 | -98.65% |
| Dec 31, 2022 | -95.35% |
| Sep 30, 2022 | 112.58% |
| Jun 30, 2022 | -80.85% |
| Mar 31, 2022 | 145.32% |
| Dec 31, 2021 | 180.37% |
| Sep 30, 2021 | 188.48% |
| Jun 30, 2021 | 32.59% |
| Mar 31, 2021 | 0.93% |
| Dec 31, 2020 | -21.57% |
| Sep 30, 2020 | -204.20% |
| Jun 30, 2020 | 84.58% |
| Mar 31, 2020 | 80.00% |
| Dec 31, 2019 | 162.54% |
| Sep 30, 2019 | -76.53% |